Nilemdo 180 mg film-coated tablets
Sponsors
Medizinische Hochschule Hannover, A. Menarini International Licensing S.A.
Conditions
Coronary artery disease/myocardial infarctionDyslipidemia at High to Very High Cardiovascular Risk
Phase 3
A prospective, interventional, single-center, single-arm study to assess the effectiveness of Bempedoic acid to achieve LDL-cholesterol targets in patients following ST-elevation or Non-ST-elevation myocardial infarctions insufficiently treated with atorvastatin plus ezetimibe (HACOL-ACS)
RecruitingCTIS2024-513703-13-00
Start: 2023-06-30Target: 135Updated: 2025-02-11
A Double-Blind, Randomized, Comparative Study of Obicetrapib and Bempedoic Acid on top of Maximally Tolerated Lipid-Lowering Therapy in Patients With Dyslipidemia at High to Very High Cardiovascular Risk (MEDICI Study)
Not yet recruitingCTIS2025-524265-24-00
Target: 108Updated: 2026-05-12